Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
ADHD Attention Deficit and Hyperactivity Disorders
Published in: ADHD Attention Deficit and Hyperactivity Disorders 1/2017

01-03-2017 | Original Article

The role of sleep quality and quantity in moderating the effectiveness of medication in the treatment of children with ADHD

Authors: Jessica Morash-Conway, Melissa Gendron, Penny Corkum

Published in: ADHD Attention Deficit and Hyperactivity Disorders | Issue 1/2017

Login to get access

Abstract

The current study examined: (1) whether long-acting stimulant medication is effective in improving performance on measures of memory, attention, and academic productivity; and (2) whether sleep impacts the relationship between medication and performance. Participants were 21 newly diagnosed, medication-naïve children (mean age = 9.1 years) with ADHD, who participated in a 4-week blinded placebo-controlled randomized trial of long-acting MPH. Participants underwent assessments of sleep (i.e., polysomnography) and of cognitive performance. Long-acting stimulant medication was found to be an effective treatment for enhancing alerting attention, executive attention, working memory, and academic productivity, but resulted in poorer sleep. Moreover, sleep duration was found to impact the treatment response to medication, in that longer sleep duration at baseline was related to improved executive attention. These results underscore the importance of evaluating and monitoring sleep when prescribing stimulant medication as a treatment for ADHD in children.
Literature
American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4 TR edn. American Psychiatric Association, Washington, DC
American Psychiatric Association (2014) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Association, Washington, DC
Barkley RA (2006) Attention deficit hyperactivity disorder: a handbook for diagnosis and treatment, 3rd edn. Guilford Press, New York
Bedard AC, Tannock R (2008) Anxiety, methylphenidate response, and working memory in children with ADHD. J Atten Disord 11(5):546–557CrossRefPubMed
Bonnet MH, Balkin TJ, Dinges DF, Roehrs T, Rogers NL, Wesensten NJ (2005) The use of stimulants to modify performance during sleep loss: a review by the sleep deprivation and stimulant task force of the American Academy of Sleep Medicine. Sleep 28(9):1163–1187PubMed
Callejas A, Lupianez J, Jesus-Funes M (2005) Modulations among the alerting, orienting and executive control networks. Exp Brain Res 167:27–37CrossRefPubMed
Charach A, Volpe T, Boydell KM, Gearing RE (2008) A theoretical approach to medication adherence for children and youth with psychiatric disorders. Harv Rev Psychiatry 16:126–135CrossRefPubMed
Chaytor N, Schmitter-Edgecombe M (2003) The ecological validity of neuropsychological tests: a review of the literature on everyday cognitive skills. Neuropsychol Rev 13(4):181–196CrossRefPubMed
Corkum P, Panton R, Ironside S, MacPherson M, Williams T (2008) Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder. J Pediatr Psychol 33(4):368–379CrossRefPubMed
Corkum P, McGonnell M, Schachar R (2010) Factors affecting academic achievement in children with ADHD. J Appl Res Learn 3(9):1–14
Corkum P, Davidson F, MacPherson M (2011) A framework for the assessment and treatment of sleep problems in children with attention-deficit/hyperactivity disorder. Pediatr Clin North Am 58(3):667–683CrossRefPubMed
Fan J, McCandliss B, Sommer T, Raz A, Posner MI (2002) Testing the efficiency and independence of attentional networks. J Cogn Neurosci 14(3):340–347CrossRefPubMed
Faraone SV, Glatt SJ (2010) A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry 71:754–763CrossRefPubMed
Gruber R, Grizenko N, Schwartz G, Bellingham J, Guzman R, Joober R (2007) Performance on the continuous performance test in children with ADHD is associated with sleep efficiency. Sleep Pediatric ADHD 30(8):1003–1009
Gruber R, Wiebe S, Montecalvo L, Brunetti B, Amsel R, Carrier J (2011) Impact of sleep restriction on neurobehavioral functioning of children with attention deficit hyperactivity disorder. Sleep 34(3):315–323PubMedPubMedCentral
Ironside S, Davidson F, Corkum P (2010) Circadian motor activity affected by stimulant medication in children with ADHD. J Sleep Res 9:546–551CrossRef
Ishigami Y, Klein RM (2010) Repeated measurement of the components of attention using two versions of the attention network task (ANT): stability, isolability, robustness, and reliability. J Neurosci Methods 190(1):117–128CrossRefPubMed
Konrad K, Gunther T, Hanish C, Herpertz-Dahlmann B (2004) Differential effects of methylphenidate on attentional function in children with ADHD. J Am Acad Child Adolesc Psychiatry 43:191–198CrossRefPubMed
Loe IM, Feldman HM (2007) Academic and educational outcomes of children with ADHD. J Pediatr Psychol 32(6):643–654CrossRefPubMed
Martinussen R, Hayden J, Hogg-Johnson S, Tannock R (2005) A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 44(4):377–384CrossRefPubMed
McGonnell M, Corkum P, McKinnon M, MacPherson M, Williams T, Davidson C, Stephenson D (2009) Doing it right: an interdisciplinary model for the diagnosis of ADHD. J Can Acad Child Adoles Psychiatry 18(4):283–286
Mehta M, Goodyer I, Sahakian B (2004) Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity. J Child Psychol Psychiatry 45:293–305CrossRefPubMed
Mick E, Biederman J, Jetton J, Faraone SV (2000) Sleep disturbances associated with attention deficit hyperactivity disorder: the impact of psychiatric comorbidity and pharmacotherapy. J Child Adolesc Psychopharmacol 10(3):223–231CrossRefPubMed
Mullane JC, Corkum PV, Klein RM, McLaughlin EN, Lawrence MA (2011) Alerting, orienting, and executive attention in children with ADHD. J Atten Disord 15(4):310–320CrossRefPubMed
Muto V, Shaffii-LE Bourdiec A, Matarazzo L, Foret A, Macetti L, Jaspar M, Vandewalle G, Phillips C, Degueldre C, Balteau E, Luxen A, Collette F, Maquet P (2012) Influence of acute sleep loss on the neural correlates of alerting, orienting and executive attention components. J Sleep Res 21(6):648–658CrossRefPubMed
Oberlin BG, Alford JL, Marrocco RT (2005) Normal attention orienting but abnormal stimulus alerting and conflict in combined subtype of ADHD. Behav Brain Res 165:1–11CrossRefPubMed
Olson K, Jacobson KK, Van Oot P (2013) Ecological validity of pediatric neuropsychological measures: current state and future directions. Appl Neuropsychol 2(1):17–23CrossRef
Owens JA (2009) A clinical overview of seep and attention-deficit/hyperactivity disorder in children and adolescents. J Can Acad Child Adoles Psychiatry 18(2):92–102
Owens J, Gruber R, Brown T, Corkum P, Cortese S, O’Brien L, Stein M, Weiss M (2012) Future research directions in sleep and attention deficit hyperactivity disorder: report of a consensus working group. J Atten Disord 17(7):550–564CrossRefPubMed
Raggi VL, Chronis AM (2006) Interventions to address the academic impairment of children and adolescents with ADHD. Clin Child Fam Psychol Rev 9(2):85–111CrossRefPubMed
Repantis D, Schlattmann P, Laisney O, Heuser I (2010) Modafinil and methylphenidate for neuroenhancement in health individuals: a systematic review. Pharmacol Res 62:187–206CrossRefPubMed
Sadeh A (2007) Consequences of sleep loss or sleep disruption in children. Sleep Med Clin 2:513–520CrossRef
Speth T, Benoit A, Corkum P (2015) Sleep parameters and architecture in children with attention-deficit/hyperactivity disorder: a comparison with typically developing peers and across subtypes. J Sleep Disord Treat Care 4:1
Steenari MM, Vuontela V, Paavonen J, Carlson S, Fjallberg M, Aronen ET (2003) Working memory and sleep in 6- to 13-year-old school children. J Am Acad Child Adoles Psychiatry 42(1):85–92CrossRef
Stein MA, Sarampote CS, Waldman IP, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH (2003) A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics 115(5):404–413CrossRef
Swanson JM, Baler RD, Volkow ND (2011) Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress. Neuropsychopharmacology 36:207–226CrossRefPubMed
Vriend JL, Davidson FD, Corkum PV, McLaughlin EN, Chambers CT (2012) Sleep quantity and quality in relation to daytime functioning in children. Children’s Health Care 41(3):204–222CrossRef
Vriend JL, Davidson FD, Corkum PV, Rusak B, Chambers CT, McLaughlin EN (2013) Manipulating sleep duration alters emotional functioning and cognitive performance in children. J Pediatr Psychol 38(10):1058–1069CrossRefPubMed
Wigal SB, Wigal T, Schuck S, Brams M, Williamson D, Armstrong RB, Starr HL (2011) Academic, behavioural, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 21(2):121–131CrossRefPubMedPubMedCentral
Wigal SB, Greenhill LL, Nordbrock E, Connor DF, Kollins SH, Adjei A, Ann Childress, Stehli A, Kupper RJ (2014) A randomized placebo-controlled double-blind study evaluating the time course of response to methylphenidate hydrochloride extended-release capsules in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 24(10):562–569CrossRefPubMedPubMedCentral
Wolraich ML, McGuinn L, Doffing M (2007) Treatment of attention deficit hyperactivity disorder in children and adolescents: safety considerations. Drug Saf 30:17–26CrossRefPubMed
Wolraich M, Brown L, Brown RT, DuPaul G, Earls M, Feldman HM, Ganiats TG, Kaplanek B, Meyer B, Perrin J, Pierce K, Reiff M, Stein MT, Visser S (2011) ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 128:1007–1022CrossRefPubMed
Metadata
Title
The role of sleep quality and quantity in moderating the effectiveness of medication in the treatment of children with ADHD
Authors
Jessica Morash-Conway
Melissa Gendron
Penny Corkum
Publication date
01-03-2017
Publisher
Springer Vienna
Published in
ADHD Attention Deficit and Hyperactivity Disorders / Issue 1/2017
Print ISSN: 1866-6116
Electronic ISSN: 1866-6647
DOI
https://doi.org/10.1007/s12402-016-0204-7

Other articles of this Issue 1/2017

ADHD Attention Deficit and Hyperactivity Disorders 1/2017 Go to the issue

Review Article

Is there a difference between child self-ratings and parent proxy-ratings of the quality of life of children with a diagnosis of attention-deficit hyperactivity disorder (ADHD)? A systematic review of the literature

Acknowledgement

Acknowledgement to reviewers 2016

Original Article

The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys

Editorial

What are the benefits of methylphenidate as a treatment for children and adolescents with attention-deficit/hyperactivity disorder?

Original Article

Do Adult Attention Deficit Hyperactivity Disorder Quality-Of-Life (AAQoL) scale and the SF-36 scale measure the same construct of health-related quality of life?

Review Article

Attention, reward, and inhibition: symptomatic features of ADHD and issues for offenders in the criminal justice system